Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2425]

Second-line cetuximab active beyond progression in quadruple wild-type patients with mCRC

Second-line cetuximab active beyond progression in quadruple wild-type patients with mCRC

Studies confirm regorafenib benefit in pre-treated metastatic colorectal cancer

Studies confirm regorafenib benefit in pre-treated metastatic colorectal cancer

SENRI trial opens window to evaluate NK1 antagonists for emesis prevention in oxaliplatin chemotherapy

SENRI trial opens window to evaluate NK1 antagonists for emesis prevention in oxaliplatin chemotherapy

Researchers develop new breath test to diagnose oesophageal and gastric cancer

Researchers develop new breath test to diagnose oesophageal and gastric cancer

Cancer charity welcomes update guideline from NICE on colorectal cancer

Cancer charity welcomes update guideline from NICE on colorectal cancer

Genomic testing can help identify patients at heightened risk for oesophageal cancer

Genomic testing can help identify patients at heightened risk for oesophageal cancer

Mouse models of human colorectal cancer generated through chemokine targeting

Mouse models of human colorectal cancer generated through chemokine targeting

ASCO 2015: Genomic marker predicts anti-PD-1 response in several cancers

ASCO 2015: Genomic marker predicts anti-PD-1 response in several cancers

Alarm bells are ringing for patients in england says bowel cancer UK

Alarm bells are ringing for patients in england says bowel cancer UK

Lower cancer survival in UK linked to delays in referring patients for tests

Lower cancer survival in UK linked to delays in referring patients for tests

More from ecancer